Senior insider sale
SVP, GC & Corporate Secretary at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$503.9K
17.18K shares
What this filing means
REED ELIZABETH E plans to sell 17.18K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $503.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/3/2026ACC: 0001193125-26-036479
Officer· SVP, GC & Corporate Secretary
Since Nov 2018
17.18K
Shares to sell
$503.9K
Approx. market value
7.17K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
1/31/2026
7.17KTotal acquired7.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted Stock Unit Vesting Compensation | 7.17K | — |
| Total | 7.17K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$273.4K
1/20/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.17K
Market value
$230.5K
2/3/2026
Total
Units
17.18K
Value
$503.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/20/2026 | 10K | $273.4K | — | Completed |
| Planned — Approximate Date | ||||
2/3/2026 | 7.17K | $230.5K | NASDAQ | Planned |
| Total | 17.18K | $503.9K | ||